Evidence map›Paper›PMID 41191359›Full record

ArticleJAMA network open2025

Hearing Loss, Brain Structure, Cognition, and Dementia Risk in the Framingham Heart Study.

Francis B Kolo, Sophia Lu, Alexa S Beiser, Lily Francis, Debora Melo van Lent, Monica Gireud-Goss, Jayandra J Himali, Saptaparni Ghosh, Shu Jie Ting, Ayantika Banerjee and 10 more

Abstract read
In one paragraph

Article in JAMA network open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Study design and results of the Wave VI Add Health Cognitive Assessment, Physical, and Sensory Function (Add CAPS) protocol.The journals of gerontology. Series B, Psychological sciences and social sciences · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Francis B KoloGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, The University of Texas Health Science Center at San Antonio.
Sophia LuDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Alexa S BeiserDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Lily FrancisGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, The University of Texas Health Science Center at San Antonio.
Debora Melo van LentGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, The University of Texas Health Science Center at San Antonio.
Monica Gireud-GossGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, The University of Texas Health Science Center at San Antonio.
Jayandra J HimaliGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, The University of Texas Health Science Center at San Antonio.
Saptaparni GhoshFramingham Heart Study, Framingham, Massachusetts.
Shu Jie TingFramingham Heart Study, Framingham, Massachusetts.
Ayantika BanerjeeFramingham Heart Study, Framingham, Massachusetts.
Timothy L KowalczykFramingham Heart Study, Framingham, Massachusetts.
Jared M ZuckerSarah Cannon Research Institute, Cambridge, Massachusetts.
Nancy Heard-CostaDepartment of Biostatistics, Boston University School of Public Health, Boston, Massachusetts.
Christopher G WoodHarvard Medical School, Department of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital Boston.
Pauline MaillardDepartment of Neurology and Imaging of Dementia and Aging Laboratory, University of California Davis, Sacramento.
Evan M FletcherDepartment of Neurology and Imaging of Dementia and Aging Laboratory, University of California Davis, Sacramento.
Charles S DeCarliDepartment of Neurology and Imaging of Dementia and Aging Laboratory, University of California Davis, Sacramento.
D Bradley WellingHarvard Medical School, Department of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital Boston.
Sharon G KujawaHarvard Medical School, Department of Otolaryngology Head and Neck Surgery, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital Boston.
Sudha SeshadriGlenn Biggs Institute for Alzheimer's and Neurodegenerative Diseases, The University of Texas Health Science Center at San Antonio.

Funding

Multidimensional Assessment of Brain Health as A Marker of Dementia Risk and ResilienceR01AG066524 · NIA · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI KASHANI, AMIR H, RAMACHANDRAN, VASAN S · 2020 to 2024
$9.7M
NIA NIH HHS R01 AG066524
6 · The paper itself

Abstract

Importance: Age-related hearing loss is a potentially modifiable risk factor for cognitive impairment and dementia. Objective: To investigate the association of hearing loss with brain structure changes, cognitive function, and incident dementia. Design, Setting, and Participants: This cohort study included Framingham Heart Study Offspring Study participants attending their sixth quadrennial examination (1995-1998) divided into 2 partially overlapping samples. Sample 1 participants underwent brain magnetic resonance imaging and cognitive assessment at their seventh and eighth quadrennial examinations. Sample 2 included participants aged 60 years or older at pure tone average (PTA) analysis and subsequently followed up for incident dementia. The data analysis was performed between January 12, 2024, and August 24, 2025. Exposure: Hearing loss. Main Outcomes and Measures: The main outcomes were changes in brain volume on MRI, cognitive performance on neuropsychological testing, and incident all-cause dementia. Multivariable linear regressions were used to compare PTA and hearing loss categories with neuropsychological measures and total cerebral, hippocampal, and white matter hyperintensity brain volumes. Cox proportional hazards regression was used to examine longitudinal associations between PTA and hearing loss categories and incident dementia. Results: Sample 1 included 1656 participants (mean [range] age, 58.1 [29.7-85.6] years; 903 female [54.5%]), and sample 2 included 935 participants (mean [range] age, 67.6 [60.0-85.6] years; 518 female [55.4%]). Participants with mild or greater hearing loss, compared with those with no or only slight hearing loss, had significantly smaller brain volumes (β [SE], -4.10 [1.76]) and declines in executive function (β [SE], -0.04 [0.01]). Participants with at least slight hearing loss, compared with those with no hearing loss, had significant increases in white matter hyperintensity volume (β [SE], 0.02 [0.01]) and a higher risk of developing all-cause dementia (hazard ratio, 1.71; 95% CI, 1.01-2.90) over 15 years of follow-up, particularly among those with at least 1 apolipoprotein E ε4 allele (hazard ratio, 2.86; 95% CI, 1.12-7.28). Conclusions and Relevance: This cohort study found that midlife hearing loss was associated with smaller brain volumes, accelerated worsening in executive function, and an increased risk of dementia, suggesting that it may be an early marker of brain aging and dementia risk.

Indexed as

BrainCognitionDementiaHearing LossAgedAged, 80 and overCohort StudiesFemaleHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedNeuropsychological TestsRisk Factors

Identifiers

PMID41191359
PMCPMC12590305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.